• Wed, August 2, 2023
Mayank Mamtani Maintained (TGTX) at Strong Buy with Decreased Target to $32 on, Aug 2nd, 2023
Mayank Mamtani of B. Riley Securities, Maintained "TG Therapeutics, Inc." (TGTX) at Strong Buy with Decreased Target from $42 to $32 on, Aug 2nd, 2023.
Mayank has made no other calls on TGTX in the last 4 months.
There are 3 other peers that have a rating on TGTX. Out of the 3 peers that are also analyzing TGTX, 0 agree with Mayank's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Mayank
- Edward White of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $41 on, Tuesday, August 1st, 2023
- Matthew Kaplan of "Ladenburg Thalmann" Maintained at Strong Buy with Increased Target to $38 on, Tuesday, May 2nd, 2023
- Prakhar Agrawal of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $24 on, Monday, April 17th, 2023
Like: 👍
